Skip to main content
OpenTrials
Completed

NCT Number: NCT03627806

FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)

In this study, FL-PR Stroke Registry will be used to determine novel data on disparities in stroke care and outcomes for patients with Atrial Fibrillation (AF) in 'real life' hospital setting. Investigators will evaluate clinical practice for AF detection and treatment in stroke patients within large stroke hospital systems of care with multi-ethnic patient populations and thereby representative of the states of Florida and Puerto Rico. The results of this study will be of critical importance for secondary stroke prevention by identifying gaps in stroke care for patients with AF and by recognizing the needs for developing targeted interventions to reduce disparities in diverse populations of stroke patients with AF and improve systems of care for all stroke patients with AF.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Miami

Miami, Florida, 33136, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age is 18 and older
  • primary diagnosis of ischemic stroke
  • enrolled in the Florida - Puerto Rico Stroke Registry

Exclusion criteria

  • primary diagnosis of intracerebral hemorrhage
  • diagnosis of subarachnoid hemorrhage
  • stroke not otherwise specified
  • no stroke related diagnosis
  • admission for elective carotid intervention only

Treatment and study plan

Primary outcomes

  1. In-Hospital Quality of Care Acute Stroke Measures

    Time frame: 5 years

    As measured by modified rankin score (mRS) at discharge (a score that measures the degree of disability or dependence in the daily activities of people who have suffered a stroke). A minimum score of 0 indicates no symptoms and therefore no disability. A maximum score of 6 indicates death has resulted

Secondary outcomes

  1. Temporal trends of atrial fibrillation for stroke outcomes

    Time frame: 5 years

    Changes in the occurrence of atrial fibrillation (AF) and its effect on related hospital discharge characteristics among stroke patients

  2. Temporal trends in the frequency of hospital prescriptions at discharge of anticoagulants for stroke patients

    Time frame: 5 years

    Changes over the years measured through the quantification of the frequency hospitals prescribe anticoagulants (i.e., aspirin, warfarin, and novel oral anticoagulants) at discharge

  3. Temporal trends in the frequency of hospital prescriptions for atrial fibrillation monitoring devices

    Time frame: 5 years

    Changes over the years measured through the quantification of the frequency hospitals prescribe atrial fibrillation monitoring devices (i.e., Holter monitoring and prolonged electrocardiogram monitoring).

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Collaborators

  • Bristol-Myers Squibb

Registry information

Official study title

Disparities in Stroke Outcomes and Care Delivery in Patients With Atrial Fibrillation: FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)

Acronym: FLiPER-AF

Important dates

Study start
2010
Primary completion
2021
Study completion
2021
First posted
Aug 13, 2018
Registry last updated
Feb 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.